Related Experiment Videos
Central pain in cancer patients
Gilbert R Gonzales1, Sara L Tuttle, Howard T Thaler
1Department of Neurology, Section of Pain and Palliative Care, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
The Journal of Pain
|November 19, 2003
Summary
Central pain (CP) affects 2-4% of hospitalized cancer patients. Causes include tumors and cancer treatments, with spinal cord tumors posing a higher risk than brain tumors.
Area of Science:
- Oncology
- Neurology
- Pain Medicine
Background:
- Central pain (CP) is a debilitating condition resulting from damage to the central nervous system (CNS).
- The prevalence and characteristics of CP in cancer patients remain largely undefined.
- Understanding CP is crucial for improving pain management in oncology.
Purpose of the Study:
- To determine the prevalence of central pain in hospitalized cancer patients.
- To identify potential causes and risk factors for central pain in this population.
- To characterize the clinical presentation of central pain in cancer patients.
Main Methods:
- A retrospective review of medical records was conducted.
- Patients evaluated by the Pain Service and Neurology Service at Memorial Sloan-Kettering Cancer Center were included.
- Data on tumor type, cancer therapy, and pain characteristics were analyzed.
Main Results:
- The prevalence of central pain was found to be 4% in patients seen by the Pain Service and 2% by the Neurology Service.
- Potential causes of CP included primary and metastatic tumors, as well as cancer therapies (surgery, radiation, chemotherapy).
- Patients with primary CNS tumors had a higher incidence of CP if they had spinal cord tumors compared to brain tumors (P <.0001).
Conclusions:
- Central pain is a relevant issue in hospitalized cancer patients, affecting 2-4% of those evaluated.
- Cancer and its treatments are significant contributors to the development of central pain.
- Spinal cord tumors represent a particularly high-risk factor for developing central pain in cancer patients.